VBH-87397-99938
5 vaccinations
3 coded responses
22 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 900 / CA
- Registered
- 2021-03-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-06
Dose 1 — Pfizer-BioNTech
-
2021-03-27
Dose 2 — Pfizer-BioNTech
-
2021-03-28
Registered in v-safe
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness · Headache, Fatigue or tirednessAdult check-in
-
2021-03-31
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-12
- 2021-04-17
-
2021-04-24
Survey response — day 28, dose 2MedDRA: Urinary tract infection — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: UTIMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-24
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-01
- 2021-05-10
-
2021-06-26
Survey response — 3 months, dose 2MedDRA: Heavy menstrual bleeding — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Noticed change in menstrual period- heavier and consistencyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-25
-
2021-11-01
Dose 3 — Moderna
- 2022-04-07
-
2022-05-20
Dose 4 — Moderna
-
2022-09-30
Dose 5 — Moderna
-
2022-10-01
Survey response — days 1–6 daily, dose 5MedDRA: Decreased appetite — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Loss of appetiteMedDRA releases: 2024-11 · check-in free text available
-
2022-10-02
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-03
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2022-10-04
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-05
- 2022-10-06
- 2022-10-07
- 2022-10-21
- 2022-11-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Pfizer-BioNTech | |
| 2 | 2021-03-27 | Pfizer-BioNTech | |
| 3 | 2021-11-01 | Moderna | No |
| 4 | 2022-05-20 | Moderna | No |
| 5 | 2022-09-30 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-24 | Unsuccessful |
Free text
Release 7 — day 28, dose 2
Symptoms: UTI
Release 9 — 3 months, dose 2
Symptoms: Noticed change in menstrual period- heavier and consistency
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Loss of appetite
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Urinary tract infection | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release